MONASH University Biomedicine Discovery Institute's Head of Respiratory Pharmacology, Associate Professor Jane Bourke has been awarded funding totalling $416,000 across two research projects on silicosis.
An incurable and deadly occupational lung disease, silicosis has as many as 600 cases already and is expected to rise to more than 100k across Australia.
The first project will look at early screening to see if people have chemical signatures for the disease.
The second project is to test therapeutic agents which can ameliorate or prevent progression of lung scarring characteristic of silicosis.
The above article was sent to subscribers in Pharmacy Daily's issue from 12 May 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 12 May 23
